Commercial Litigation UK

  • March 28, 2025

    TUI Denies Liability For Holidaymakers' Illness In Mexico

    TUI has hit back against a claim from 23 holidaymakers who say they were struck with gastroenteritis during a stay at a resort in Mexico, saying the customers must prove the illness was caused by food consumed during the all-inclusive vacation package.

  • March 28, 2025

    AstraZeneca Sues Consultancy For £32M Over HQ Defects

    AstraZeneca UK Ltd. has sued a fire engineering consultancy for £31.7 million ($41.1 million) over allegedly "widespread" fire protection defects uncovered at the biotechnology company's £1 billion headquarters in Cambridge.

  • March 28, 2025

    Tesco Can't Add New Alleged 'Errors' To Equal Pay Appeal

    An attempt by retail giant Tesco to add a broad challenge to alleged factual errors in a claim for equal pay brought by more than 50,000 female shop floor workers was tossed by an appeals tribunal on Friday.

  • March 28, 2025

    AstraZeneca Can't Stop Generic Diabetes Drug Launch

    AstraZeneca has lost an attempt to prevent pharmaceutical company Glenmark from launching a generic version of its $1 billion diabetes drug Forxiga, as a London court refused on Friday to stop the generic maker before a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    Oligarch's Ex-Wife Ends Payne Hicks Negligence Case

    A Russian oligarch's former wife has ended a negligence action against Payne Hicks Beach LLP over claims it failed to exercise the proper care and skill in a divorce battle involving the oligarch's £200 million ($260 million) yacht.

  • March 27, 2025

    Railway Questions Class Rep's Suitability In Fare Dispute

    Govia Thameslink Railway Ltd. asked the U.K.'s antitrust tribunal on Thursday to demand extra evidence from the campaigner seeking to represent rail passengers in a class action over allegedly unfair ticket prices, saying he must prove he is a suitable representative.

  • March 27, 2025

    AstraZeneca Fights Generic Diabetes Drug Launch

    AstraZeneca on Thursday asked a London court to block pharmaceutical company Glenmark from launching a generic version of the drug giant's $1 billion Type 2 diabetes treatment Forxiga, ahead of a decision on whether AstraZeneca's patent is valid.

  • March 27, 2025

    WhatsApp Should Get To Fight €225M GDPR Fine, ECJ Urged

    WhatsApp should be allowed to challenge a European Union board's order for Irish authorities to increase a data protection fine that topped out at €225 million ($243 million), an adviser to the bloc's top court said Thursday.

  • March 27, 2025

    'A Challenge We Have To Rise To': Class Reps Take The Stage

    Launching a series of interviews with lawyers, class representatives and litigation-funders to mark the 10-year anniversary of the collective proceedings order regime, Law360 spoke to Justin Gutmann and Rachael Kent about how the role of class reps has evolved in the decade since CPOs were introduced

  • March 27, 2025

    Key Moments That Formed The UK's Class Action Regime

    The U.K.'s collective proceedings regime — introduced a decade ago — has grown rapidly after a slow start. Law360 looks here at the biggest moments of the regime so far and what's ahead.

  • March 27, 2025

    Huawei Defeats Widow's Delayed Claim Over Unpaid OT

    A former Huawei employee's widow can't pursue the company for allegedly discriminating against her husband because she waited too long to launch her case, an employment tribunal has ruled.

  • March 27, 2025

    Former Barclays Exec Fights For £3.5M Deferred Bonus

    A former head of credit trading at Barclays has argued that he is owed a £3.5 million ($4.5 million) bonus package after he left the bank and joined a hedge fund following his son's diagnosis with a rare disease.

  • March 27, 2025

    Top EU Court Urged To Uphold €60M Teva Pay-For-Delay Fine

    An adviser to the European Union's top court said Thursday that it should uphold €60.5 million ($70.7 million) in fines against Teva and its subsidiary Cephalon for an alleged conspiracy to keep a generic version of Provigil off the shelves.

  • March 26, 2025

    Claims Firm Beats Whistleblower's Fraud Case

    A claims manager didn't blow the whistle on forged signatures at an insurance claims handler because he had waited until his resignation day to alert senior management, an employment tribunal has ruled.

  • March 26, 2025

    10 Years On, CPO Regime's Success Hinges On Payouts

    It's 10 years since the U.K. government approved legislation for opt-out collective actions, but lawyers believe it is still too early to tell whether the regime is working as it should be judged by what money ends up in the hands of consumers.

  • March 26, 2025

    Jury's Still Out: Law360 Looks At Decade Of UK Class Actions

    Ten years after the Consumer Rights Act received formal approval in March 2015, lawyers are still grappling with the opt-out class action regime it introduced in the U.K. for the first time for competition claims.

  • March 26, 2025

    Ex-Law Firm Boss Denies Conspiring To Steal Probate Clients

    The former boss of a law firm has denied conspiring to steal clients and business from a probate firm to advance her own interests, telling a London court that there is no evidence of such a plot.

  • March 26, 2025

    French Co. Fails To Win Arbitration Bid In Payment Dispute

    French engineering company Saipem SA has lost its bid for a stay in a London court as it looks to arbitrate claims asserted by Panamanian logistics provider Destin Trading Inc. related to an alleged $7 million shortfall in payment for a Congo River project.

  • March 26, 2025

    Software Developer Loses 'Baidu' TM On Appeal

    A Dutch provider of software for TV channels has lost its rights to use "Baidu" as a trademark, after a European court found that it hadn't used the name to market goods and services it had applied for.

  • March 26, 2025

    Judge's Relative Can't Quash 'Merciful' Sentence On Appeal

    A London appeals court on Wednesday upheld a "merciful" decision to suspend a man's jail sentence following his baseless accusations that his brother-in-law, a judge, was engaged in fraud and money laundering.

  • March 26, 2025

    Civil Service Cuts Could Have 'Significant' Impact On MoJ

    The U.K. government said Wednesday it will cut administration costs in the civil service by 15% by the end of the decade, in a move that a trade union warned could have "significant ramifications" for the Ministry of Justice.

  • March 26, 2025

    Lotus Biscoff Loses EU Appeal To Register Color TM

    Lotus Bakeries NV has lost another bid to protect the red and white coloring of its biscuit packaging after failing to convince European officials that shoppers would immediately recognize its brand.

  • March 26, 2025

    WeRealize Denies JPMorgan's Breach Claim In JV Dispute

    Fintech business WeRealize has hit back at a JPMorgan Chase & Co. unit's latest claim in a protracted battle, denying allegations that it was planning to breach the terms of a joint venture shareholder agreement.

  • March 26, 2025

    Odey Sexual Misconduct Stories In Public Interest, FT Says

    The Financial Times has denied hedge fund manager Crispin Odey's £79 million ($102 million) defamation claim relating to articles containing allegations that he sexually assaulted multiple women, arguing that the stories were true and in the public interest.

  • March 26, 2025

    Major Banks Lose Challenge To EU Bond Cartel Ruling

    A group of banks lost their challenge on Wednesday to a finding by a European Union antitrust watchdog that they took part in a bond price-fixing cartel, a breach of competition law in which UBS, Nomura and UniCredit were fined €371 million ($400 million).

Expert Analysis

  • EU Report Is A Valuable Guide For Data Controllers

    Author Photo

    The European Data Protection Board recently published a study of cases handled by national supervisory authorities where uniform application of the General Data Protection Regulation was prioritized, providing data controllers with arguments for an adequate response to manage liability in case of a breach and useful insights into how security requirements are assessed, say Thibaut D'hulst and Malik Aouadi at Van Bael.

  • UK Court Ruling Reinforces CMA's Info-Gathering Powers

    Author Photo

    An English appeals court's recent decision in the BMW and Volkswagen antitrust cases affirmed that the U.K. Competition and Markets Authority can request information from entities outside the U.K., reinstating an important implement in the CMA's investigative toolkit, say lawyers at White & Case.

  • UK Ruling Revitalizes Discussions On Harmonizing AI And IP

    Author Photo

    The U.K. Supreme Court's decision in Thaler v. Comptroller-General last month has reinvigorated ongoing discussions about how the developments in artificial intelligence fit within the existing intellectual property legislative landscape, illustrating that effective regulation will be critical as the value and influence of this sector grows, say Nick White and Olivia Gray at Charles Russell.

  • Employers Can 'Waive' Goodbye To Unknown Future Claims

    Author Photo

    The Scottish Court of Session's recent decision in Bathgate v. Technip Singapore, holding that unknown future claims in a qualifying settlement agreement can be waived, offers employers the possibility of achieving a clean break when terminating employees and provides practitioners with much-needed guidance on how future cases might be dealt with in court, says Natasha Nichols at Farrer & Co.

  • AI Inventorship Patent Options After UK Supreme Court Ruling

    Author Photo

    The U.K. Supreme Court's recent ruling in Thaler v. Comptroller-General of Patents, Designs and Trade Marks that an AI system cannot be an inventor raises questions about alternative approaches to patent protection for AI-generated inventions and how the decision might affect infringement and validity disputes around such patents, says David Knight at Brown Rudnick.

  • Ruling Elucidates Tensions In Assessing Employee Disability

    Author Photo

    An employment tribunal's recent decision, maintaining that dermatitis was not a disability, but stress was, illustrates tensions in the interaction between statutory guidance on reasonable behavior modifications and Equality Act measures, says Suzanne Nulty at Weightmans.

  • What Extending Corporate Liability Will Mean For Foreign Cos.

    Author Photo

    Certain sections of the Economic Crime Act enacted in December 2023 make it easier to prosecute companies for economic crimes committed abroad, and organizations need to consider their exposure and the new ways they can be held liable for the actions of their personnel, say Dan Hudson at Seladore Legal and Christopher Coltart at 2 Hare Court.

  • Cos. Should Weave Metaverse Considerations Into IP Strategy

    Author Photo

    In light of the increasing importance of intellectual property protection in digital contexts, including a growing number of court rulings and recent updates to the classification of digital assets, companies should include the metaverse as part of their trademark strategy to prevent potential infringements, says Gabriele Engels at D Young & Co.

  • ECJ Ruling Triggers Reconsiderations Of Using AI In Hiring

    Author Photo

    A recent European Court of Justice ruling, clarifying that the General Data Protection Regulation could apply to decisions made by artificial intelligence, serves as a warning to employers, as the use of AI in recruitment may lead to more discrimination claims, say Dino Wilkinson and James Major at Clyde & Co.

  • Economic Crime Act Offers Welcome Reform To AML Regime

    Author Photo

    The Economic Crime and Corporate Transparency Act exemption for mixed-property transactions that came into force on Jan. 15 as part of the U.K.'s anti-money laundering regime is long overdue, and should end economic harm to businesses, giving banks confidence to adopt a more pragmatic approach, say Matthew Getz and Joseph Fox-Davies at Pallas Partners.

  • What Venice Swaps Ruling Says About Foreign Law Disputes

    Author Photo

    The English appeals court's decision in Banca Intesa v. Venice that the English law swaps are valid and enforceable will be welcomed by banks, and it provides valuable commentary on the English courts' approach toward the interpretation of foreign law, say Harriet Campbell and Richard Marshall at Penningtons Manches.

  • Key Litigation Funding Rulings Will Drive Reform In 2024

    Author Photo

    Ground-breaking judgments on disputes funding and fee arrangements from 2023 — including that litigation funding agreements could be damages-based agreements, rendering them unenforceable — will bring legislative changes in 2024, which could have a substantial impact on litigation risk for several sectors, say Verity Jackson-Grant and David Bridge at Simmons & Simmons.

  • How Data Privacy Law Cases Are Evolving In UK, EU And US

    Author Photo

    To see where the law is heading in 2024, it is worth looking at privacy litigation and enforcement trends from last year, where we saw a focus on General Data Protection Regulation regulatory enforcement actions in the U.K. and EU, and class actions brought by private plaintiffs in the U.S., say lawyers at Morgan Lewis.

  • Misleading Airline Ads Offer Lessons To Avoid Greenwashing

    Author Photo

    Following the Advertising Standards Authority's recent decision that three airlines' adverts misled customers about their environmental impact, companies should ensure that their green claims comply with legal standards to avoid risking reputational damage, which could have financial repercussions, say Elaina Bailes and Olivia Shaw at Stewarts.

  • Supreme Court Ruling Is A Gift To Insolvency Practitioners

    Author Photo

    As corporate criminal liability is in sharp focus, the Supreme Court's recent decision in Palmer v. Northern Derbyshire Magistrates' Court that administrators are not company officers and should not be held liable under U.K. labor law is instructive in focusing on the substance and not merely the title of a person's role within a company, say lawyers at Greenberg Traurig.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Commercial Litigation UK archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!